Encapsulation of trabecular meshwork mesenchymal stem cell using microfluidic system for differentiation into neuron-like cells.

IF 1.4 4区 医学 Q4 ENGINEERING, BIOMEDICAL
Sina Rahmani, Samad Nadri, Mehdi Eskandari, Hossein Mostafavi
{"title":"Encapsulation of trabecular meshwork mesenchymal stem cell using microfluidic system for differentiation into neuron-like cells.","authors":"Sina Rahmani, Samad Nadri, Mehdi Eskandari, Hossein Mostafavi","doi":"10.1177/03913988251333280","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Neurodegenerative diseases are a class of nervous system disorders characterized by progressive neuronal degeneration and loss of function. Among emerging therapeutic approaches, microfluidic-enabled stem cell encapsulation and transplantation has gained recognition as a promising strategy for mitigating neuronal damage. In this work, human mesenchymal stem cells (MSCs), isolated from trabecular meshwork (TM) tissue, were successfully encapsulated and differentiated into neural-like cells via a microfluidic platform to demonstrate their potential for neural repair applications.</p><p><strong>Materials and methods: </strong>The isolated mesenchymal stem cells were cultured on a microfluidic system (fabricated by soft lithography methods) and treated with medium containing DMEM supplemented with RA, IBMX, and forskolin for 7 days. Quantitative PCR (qPCR) were used to analyze differentiated TM-MSC and their expression of neural-like specific markers such as Nestin and b-tubulin 3.</p><p><strong>Results: </strong>qPCR analysis revealed the presence of genes characteristic of neural cells (Nestin and β-tubulin 3) in cells differentiated both within a microfluidic system and on traditional tissue culture plates (TCPS). qPCR result showed that cells on 1.5% alginate showed higher expression of β-tubulin 3 compared to those on 1% alginate, 2% alginate, and TCPS (<i>p</i> < 0.0001). In contrast, Nestin expression showed no statistically significant differences across all pairwise comparisons (<i>p</i> > 0.05 for all groups).</p><p><strong>Conclusion: </strong>The findings indicate that mesenchymal stem cells derived from the trabecular meshwork (TM-MSCs) may serve as promising candidates for cell-based therapeutic strategies. Furthermore, the microfluidic platform implemented in this study exhibits potential utility as a delivery vehicle for TM-MSCs in therapeutic interventions targeting neurological disorders.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"3913988251333280"},"PeriodicalIF":1.4000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/03913988251333280","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Neurodegenerative diseases are a class of nervous system disorders characterized by progressive neuronal degeneration and loss of function. Among emerging therapeutic approaches, microfluidic-enabled stem cell encapsulation and transplantation has gained recognition as a promising strategy for mitigating neuronal damage. In this work, human mesenchymal stem cells (MSCs), isolated from trabecular meshwork (TM) tissue, were successfully encapsulated and differentiated into neural-like cells via a microfluidic platform to demonstrate their potential for neural repair applications.

Materials and methods: The isolated mesenchymal stem cells were cultured on a microfluidic system (fabricated by soft lithography methods) and treated with medium containing DMEM supplemented with RA, IBMX, and forskolin for 7 days. Quantitative PCR (qPCR) were used to analyze differentiated TM-MSC and their expression of neural-like specific markers such as Nestin and b-tubulin 3.

Results: qPCR analysis revealed the presence of genes characteristic of neural cells (Nestin and β-tubulin 3) in cells differentiated both within a microfluidic system and on traditional tissue culture plates (TCPS). qPCR result showed that cells on 1.5% alginate showed higher expression of β-tubulin 3 compared to those on 1% alginate, 2% alginate, and TCPS (p < 0.0001). In contrast, Nestin expression showed no statistically significant differences across all pairwise comparisons (p > 0.05 for all groups).

Conclusion: The findings indicate that mesenchymal stem cells derived from the trabecular meshwork (TM-MSCs) may serve as promising candidates for cell-based therapeutic strategies. Furthermore, the microfluidic platform implemented in this study exhibits potential utility as a delivery vehicle for TM-MSCs in therapeutic interventions targeting neurological disorders.

微流控系统包封小梁网间充质干细胞向神经元样细胞分化。
目的:神经退行性疾病是一类以进行性神经元变性和功能丧失为特征的神经系统疾病。在新兴的治疗方法中,微流体驱动的干细胞包封和移植已经被认为是减轻神经元损伤的一种有前途的策略。在这项工作中,从小梁网(TM)组织中分离的人间充质干细胞(MSCs)通过微流控平台被成功包裹并分化为神经样细胞,以证明其在神经修复应用中的潜力。材料与方法:分离的间充质干细胞在微流控系统(软光板法制备)上培养,用含有DMEM、RA、IBMX、forskolin的培养基处理7天。采用定量PCR (qPCR)分析分化后的TM-MSC及其神经样特异性标志物Nestin、b-微管蛋白3的表达情况。结果:qPCR分析显示,在微流控系统和传统组织培养板(TCPS)上分化的细胞中均存在神经细胞特征基因(Nestin和β-微管蛋白3)。qPCR结果显示,1.5%海藻酸盐处理的细胞β-微管蛋白3的表达高于1%海藻酸盐、2%海藻酸盐和TCPS处理的细胞(各组p < 0.05)。结论:这些发现表明,来自小梁网(TM-MSCs)的间充质干细胞可能是基于细胞的治疗策略的有希望的候选细胞。此外,本研究中实现的微流控平台显示出作为TM-MSCs在针对神经系统疾病的治疗干预中的传递载体的潜在用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Artificial Organs
International Journal of Artificial Organs 医学-工程:生物医学
CiteScore
3.40
自引率
5.90%
发文量
92
审稿时长
3 months
期刊介绍: The International Journal of Artificial Organs (IJAO) publishes peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信